Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma Full Text
Proceedings of the National Academy of Sciences of the United States of America, 02/03/2011
Zhou S et al. – Gastrin–releasing peptide (GRP) is synthesized by pulmonary neuroendocrine cells in inflammatory lung diseases, such as bronchopulmonary dysplasia (BPD). Many BPD infants develop asthma, a serious disorder of intermittent airway obstruction.